Clinical Trial Update: Exemestane in Hormone Receptor Positive High Grade Ovarian Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial of exemestane in hormone receptor–positive high-grade ovarian cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

Sponsor: Ente Ospedaliero Ospedali Galliera | Conditions: Ovarian Cancer | Phase 3 | Status: TERMINATED